[go: up one dir, main page]

RU97115801A - METHOD FOR TREATING STENOSING LARYNGOTRACHAITIS IN CHILDREN - Google Patents

METHOD FOR TREATING STENOSING LARYNGOTRACHAITIS IN CHILDREN

Info

Publication number
RU97115801A
RU97115801A RU97115801/14A RU97115801A RU97115801A RU 97115801 A RU97115801 A RU 97115801A RU 97115801/14 A RU97115801/14 A RU 97115801/14A RU 97115801 A RU97115801 A RU 97115801A RU 97115801 A RU97115801 A RU 97115801A
Authority
RU
Russia
Prior art keywords
children
laryngotrachaitis
day
stenosing
drug
Prior art date
Application number
RU97115801/14A
Other languages
Russian (ru)
Other versions
RU2144375C1 (en
Inventor
Г.В. Медведева
А.М. Королева
Original Assignee
Смоленская государственная медицинская академия
Filing date
Publication date
Application filed by Смоленская государственная медицинская академия filed Critical Смоленская государственная медицинская академия
Priority to RU97115801A priority Critical patent/RU2144375C1/en
Priority claimed from RU97115801A external-priority patent/RU2144375C1/en
Publication of RU97115801A publication Critical patent/RU97115801A/en
Application granted granted Critical
Publication of RU2144375C1 publication Critical patent/RU2144375C1/en

Links

Claims (1)

Способ терапии стенозирующего ларинготрахеита у детей, включающий проведение антибактериальной, гормональной, десенсибилизирующей, спазмолитической, муко-, секретолитической, ферментной терапии и ингаляционное введение лекарственного препарата, отличающийся тем, что в качестве лекарственного препарата для ингаляционного введения в первый день лечения используют лейкинферон в дозе 10.000 ME по интерферону, разведенный в 5 мл 0,9% раствора хлорида натрия, со второго дня - физиологический раствор хлорида натрия, причем ингаляции проводят три раза в день по 10 мин с интервалом 4 ч до исчезновения клинических симптомов.A method for the treatment of stenosing laryngotracheitis in children, including antibacterial, hormonal, desensitizing, antispasmodic, muco, secretolytic, enzyme therapy and inhalation administration of a drug, characterized in that leukinferon at a dose of 10.000 is used as a drug for inhalation on the first day of treatment ME according to interferon, diluted in 5 ml of 0.9% sodium chloride solution, from the second day - physiological sodium chloride solution, moreover, three once a day for 10 minutes with an interval of 4 hours until the disappearance of clinical symptoms.
RU97115801A 1997-09-17 1997-09-17 Method of treatment of children with stenosing laryngotracheitis RU2144375C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU97115801A RU2144375C1 (en) 1997-09-17 1997-09-17 Method of treatment of children with stenosing laryngotracheitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU97115801A RU2144375C1 (en) 1997-09-17 1997-09-17 Method of treatment of children with stenosing laryngotracheitis

Publications (2)

Publication Number Publication Date
RU97115801A true RU97115801A (en) 1999-06-27
RU2144375C1 RU2144375C1 (en) 2000-01-20

Family

ID=20197384

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97115801A RU2144375C1 (en) 1997-09-17 1997-09-17 Method of treatment of children with stenosing laryngotracheitis

Country Status (1)

Country Link
RU (1) RU2144375C1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2221609C1 (en) * 2002-05-30 2004-01-20 Северо-Осетинская государственная медицинская академия Method for preventing recidivation of acute stenosing infantine laryngotracheites
RU2221608C1 (en) * 2002-05-30 2004-01-20 Северо-Осетинская государственная медицинская академия Method for preventing recidivation of acute stenosing infantine laryngotracheites
RU2326670C1 (en) * 2006-10-23 2008-06-20 Государственное образовательное учреждение дополнительного образования "Новокузнецкий государственный институт усовершенствования врачей Федерального агентства по здравоохранению и социальному развитию" Method of complex intensive therapy of children acute stenosing laryngotracheitis
RU2446818C1 (en) * 2010-12-01 2012-04-10 Учреждение Российской академии медицинских наук Научный центр реконструктивной и восстановительной хирургии Сибирского отделения РАМН (НЦРВХ СО РАМН) Agent for prevention of postoperative laryngeal paresis following thyroidectomy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007184C1 (en) * 1985-11-25 1994-02-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН Method of treatment of salmonellosis infection
RU2008019C1 (en) * 1986-12-24 1994-02-28 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН Method for treatment of legionellous pneumonia
RU2005476C1 (en) * 1991-07-12 1994-01-15 Биленко Николай Петрович Method for treating false croup of first degree in children
RU2097062C1 (en) * 1993-07-13 1997-11-27 Московский областной научно-исследовательский клинический институт Method of treatment of an acute stenosed laryngotracheitis in children

Similar Documents

Publication Publication Date Title
ID24901A (en) METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED
CA2129541A1 (en) Method of Promoting Nitrogen Retention in Humans
EP0911033A3 (en) Methods and compositions for the treatment of diseases with interferon while reducing side effects
SE9703191L (en) Drugs for improving muscle function duration or treatment of muscle disorders or disease
RU95101385A (en) Products containing g-csf and tnf-binding protein
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
Tegner Severe skin pain after PUVA treatment.
HUP0202525A2 (en) Mycophenolate mofetil in association with peg-ifn-alpha, medicaments and kit comprising thereof
EE04330B1 (en) Transmucosal formulations of levosimendan and their use in the manufacture of a medicament
RU97115801A (en) METHOD FOR TREATING STENOSING LARYNGOTRACHAITIS IN CHILDREN
AR029160A1 (en) THE USE OF PEGILATED INTERFERON-ALFA FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF RENAL CELL CARCINOMA, A KIT AND THE USE OF IT
HUP9900945A2 (en) Nucleoside analogs in combinative therapy of herpes simplex infections
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
ATE91890T1 (en) MANUFACTURE OF A DRUG AGAINST ARTHRITIS AND RHEUMATISM.
RU2000103385A (en) METHOD FOR TREATING ACUTE PANCREOTITIS
RU94000695A (en) Agent showing antiallergic action
RU93032284A (en) METHOD OF TREATMENT OF LUNG DISEASES
NO960347D0 (en) Use of benzydamide in the treatment of pathological conditions caused by TNF
RU93009359A (en) METHOD OF CORRECTION OF PSYCHOPATHIC BEHAVIOR IN PERSONS OF SCHIZOID WAREHOUSE
RU93002840A (en) METHOD OF TREATMENT OF CHRONIC PURULENT ENDOBRONHITIS
RU92015412A (en) METHOD OF TREATMENT OF MOTORING SENSOR AND VERBAL DISORDERS IN CHILDREN WITH HYPERKINETIC, SPASTIC AND ATONIC SYNDROMES
FR2786699B1 (en) MEDICINE, IN PARTICULAR FOR PREVENTING OR TREATING SEXUAL DYSFUNCTIONS
RU98108179A (en) METHOD FOR TREATING INFECTIOUS MONONUCLEOSIS IN CHILDREN
RU97112609A (en) METHOD FOR TREATING "METABOLIC SYNDROME X"
RU97112610A (en) METHOD FOR TREATING ARTERIAL HYPERTENSION IN THE CLIMACTERIC PERIOD